203 related articles for article (PubMed ID: 7629157)
1. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
Sun SC; Maggirwar SB; Harhaj E
J Biol Chem; 1995 Aug; 270(31):18347-51. PubMed ID: 7629157
[TBL] [Abstract][Full Text] [Related]
2. The serine/threonine phosphatase inhibitor calyculin A induces rapid degradation of IkappaBbeta. Requirement of both the N- and C-terminal sequences.
Harhaj EW; Sun SC
J Biol Chem; 1997 Feb; 272(9):5409-12. PubMed ID: 9038140
[TBL] [Abstract][Full Text] [Related]
3. Multiple structural domains within I kappa B alpha are required for its inducible degradation by both cytokines and phosphatase inhibitors.
Good LF; Maggirwar SB; Kealiher A; Uhlik M; Sun SC
Biochem Biophys Res Commun; 1996 Jun; 223(1):123-8. PubMed ID: 8660357
[TBL] [Abstract][Full Text] [Related]
4. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.
Singh S; Aggarwal BB
J Biol Chem; 1995 May; 270(18):10631-9. PubMed ID: 7738000
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.
Traenckner EB; Pahl HL; Henkel T; Schmidt KN; Wilk S; Baeuerle PA
EMBO J; 1995 Jun; 14(12):2876-83. PubMed ID: 7796813
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor.
Menon SD; Guy GR; Tan YH
J Biol Chem; 1995 Aug; 270(32):18881-7. PubMed ID: 7642544
[TBL] [Abstract][Full Text] [Related]
7. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
8. Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation.
Ponnappan U; Trebilcock GU; Zheng MZ
Exp Gerontol; 1999 Jan; 34(1):95-107. PubMed ID: 10197731
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant-inhibitable step.
Suzuki YJ; Mizuno M; Packer L
J Immunol; 1994 Dec; 153(11):5008-15. PubMed ID: 7963561
[TBL] [Abstract][Full Text] [Related]
11. The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation.
Baumann B; Kistler B; Kirillov A; Bergman Y; Wirth T
J Biol Chem; 1998 May; 273(19):11448-55. PubMed ID: 9565556
[TBL] [Abstract][Full Text] [Related]
12. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
13. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
14. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
[TBL] [Abstract][Full Text] [Related]
15. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.
Traenckner EB; Wilk S; Baeuerle PA
EMBO J; 1994 Nov; 13(22):5433-41. PubMed ID: 7957109
[TBL] [Abstract][Full Text] [Related]
16. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
17. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
Traenckner EB; Baeuerle PA
J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress.
Schoonbroodt S; Ferreira V; Best-Belpomme M; Boelaert JR; Legrand-Poels S; Korner M; Piette J
J Immunol; 2000 Apr; 164(8):4292-300. PubMed ID: 10754328
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Adam E; Quivy V; Bex F; Chariot A; Collette Y; Vanhulle C; Schoonbroodt S; Goffin V; Nguyên TL; Gloire G; Carrard G; Friguet B; De Launoit Y; Burny A; Bours V; Piette J; Van Lint C
Mol Cell Biol; 2003 Sep; 23(17):6200-9. PubMed ID: 12917341
[TBL] [Abstract][Full Text] [Related]
20. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B.
Schmidt KN; Traenckner EB; Meier B; Baeuerle PA
J Biol Chem; 1995 Nov; 270(45):27136-42. PubMed ID: 7592968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
